A detailed history of Quest Partners LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Quest Partners LLC holds 19,123 shares of ENTA stock, worth $220,296. This represents 0.02% of its overall portfolio holdings.

Number of Shares
19,123
Previous 11,588 65.02%
Holding current value
$220,296
Previous $150 Million 31.82%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$10.05 - $16.54 $75,726 - $124,628
7,535 Added 65.02%
19,123 $198 Million
Q2 2024

Aug 06, 2024

BUY
$11.43 - $17.02 $110,779 - $164,957
9,692 Added 511.18%
11,588 $150 Million
Q1 2024

May 09, 2024

SELL
$10.08 - $17.46 $136,775 - $236,914
-13,569 Reduced 87.74%
1,896 $33.1 Million
Q4 2023

Feb 09, 2024

BUY
$8.18 - $10.78 $126,503 - $166,712
15,465 New
15,465 $146 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $239M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.